Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-02-16

FDA Approved: ACCRUFER — Supplemental Application (Shield TX (UK) Ltd)

View source ↗

Summary

FDA approved a supplemental application for ACCRUFER (ferric maltol) submitted by Shield TX (UK) Ltd. The action concerns an existing approval for ferric maltol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACCRUFER (FERRIC MALTOL)

Snippet

SUPPL AP for ACCRUFER (FERRIC MALTOL)